Emergent cardiopulmonary bypass for bupivacaine cardiotoxicitySOLTESZ, Edward G; VAN PELT, Frederick; BYRNE, John G et al.Journal of cardiothoracic and vascular anesthesia. 2003, Vol 17, Num 3, pp 357-358, issn 1053-0770, 2 p.Article

Understanding the binding of daunorubicin and doxorubicin to NADPH-dependent cytosolic reductases by computational methodsPIROLLI, Davide; GIARDINA, Bruno; MORDENTE, Alvaro et al.European journal of medicinal chemistry. 2012, Vol 56, pp 145-154, issn 0223-5234, 10 p.Article

Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicityFERRI, Nicola; SIEGL, Peter; CORSINI, Alberto et al.Pharmacology & therapeutics (Oxford). 2013, Vol 138, Num 3, pp 470-484, issn 0163-7258, 15 p.Article

Does anthracycline administration by infusion in children affect late cardiotoxicity?LEVITT, G. A; DORUP, I; SORENSEN, K et al.British journal of haematology. 2004, Vol 124, Num 4, pp 463-468, issn 0007-1048, 6 p.Article

Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity : Translational ProteomicsGRATIA, Séverine; KAY, Laurence; MICHELLAND, Sylvie et al.Journal of proteomics (Print). 2012, Vol 75, Num 15, pp 4705-4716, issn 1874-3919, 12 p.Article

MYOCARDIAL STRAIN AND STRAIN RATE IN MONITORING SUBCLINICAL HEART FAILURE IN ASYMPTOMATIC LONG-TERM SURVIVORS OF CHILDHOOD CANCERMAVINKURVE-GROOTHUIS, Annelies M. C; GROOT-LOONEN, Jacqueline; MARCUS, Karen A et al.Ultrasound in medicine & biology. 2010, Vol 36, Num 11, pp 1783-1791, issn 0301-5629, 9 p.Article

Cardiotoxicity from'safe' herbomineral formulationsDWIVEDI, Shridhar; AGGARWAL, Amitesh; SHARMA, Vishal et al.Tropical doctor. 2011, Vol 41, Num 2, pp 113-115, issn 0049-4755, 3 p.Article

Molecular basis of anthracycline-induced cardiotoxicityVANDER HEIDE, Richard S; L'ECUYER, Thomas J.Heart and metabolism. 2007, Num 35, pp 5-8, issn 1566-0338, 4 p.Article

Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugsJONES, Robin L; EWER, Michael S.Expert review of anticancer therapy. 2006, Vol 6, Num 9, pp 1249-1269, issn 1473-7140, 21 p.Article

Exercise echocardiography reflects cumulative anthracycline exposure during childhoodSMIBERT, Elizabeth; CARLIN, John B; VIDMAR, Suzanna et al.Pediatric blood & cancer. 2004, Vol 42, Num 7, pp 556-562, issn 1545-5009, 7 p.Article

In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicityADAMCOVA, Michaela; SIMUNEK, Tomas; KAISEROVA, Helena et al.Toxicology (Amsterdam). 2007, Vol 237, Num 1-3, pp 218-229, issn 0300-483X, 12 p.Article

Cardiac troponin T following anthracycline chemotherapy in children and adolescentsCLARK, S. J; PIPPON, M; HEMSWORTH, S et al.Journal of chemotherapy. 2007, Vol 19, Num 3, pp 332-334, issn 1120-009X, 3 p.Article

Role of ATP-binding cassette transporters in drug distribution to the heart and protection from toxic compoundsCOUTURE, Lucie; NASH, John A; TURGEON, Jacques et al.Heart and metabolism. 2007, Num 35, pp 16-21, issn 1566-0338, 6 p.Article

Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphomaLIMAT, S; DAGUINDAU, E; CAHN, J.-Y et al.Journal of clinical pharmacy and therapeutics (Print). 2014, Vol 39, Num 2, pp 168-174, issn 0269-4727, 7 p.Article

Frontiers in Preclinical Safety Biomarkers: MicroRNAs and Messenger RNAsMIKAELIAN, Igor; SCICCHITANO, Marshall; MENDES, Odete et al.Toxicologic pathology. 2013, Vol 41, Num 1, pp 18-31, issn 0192-6233, 14 p.Article

Neuregulin-1 Attenuates Doxorubicin-induced Autophagy in Neonatal Rat CardiomyocytesTAO AN; YAN HUANG; QIONG ZHOU et al.Journal of cardiovascular pharmacology. 2013, Vol 62, Num 2, pp 130-137, issn 0160-2446, 8 p.Article

Remodeling of ventricular repolarization in a chronic doxorubicin cardiotoxicity rat modelKHARIN, Sergey; KRANDYCHEVA, Valeria; TSVETKOVA, Alena et al.Fundamental & clinical pharmacology. 2013, Vol 27, Num 4, pp 364-372, issn 0767-3981, 9 p.Article

Protective Effects of Vitamin E and Selenium Against Dimethoate-Induced Cardiotoxicity In Vivo: Biochemical and Histological StudiesIBTISSEM BEN AMARA; SOUDANI, Nejla; HAKIM, Ahmed et al.Environmental toxicology. 2013, Vol 28, Num 11-12, pp 630-643, issn 1520-4081, 14 p.Article

A tyrosine kinase inhibitor-induced myocardial degeneration in rats through off-target phosphodiesterase inhibitionWENYUE HU; HIRAKAWA, Brad; JESSEN, Bart et al.JAT. Journal of applied toxicology. 2012, Vol 32, Num 11-12, pp 1008-1020, issn 0260-437X, 13 p.Article

Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturationJIANJIAN SHI; LUMIN ZHANG; ZHANG, Yi-Wei et al.American journal of physiology. Heart and circulatory physiology. 2012, Vol 71, Num 4, issn 0363-6135, H1603-H1613Article

Myocardial Mitochondrial Injury Induced by Pulmonary Exposure to Particulate Matter in RatsGOLOMB, Eliahu; MATZA, Didi; CUMMINGS, Connie A et al.Toxicologic pathology. 2012, Vol 40, Num 5, pp 779-788, issn 0192-6233, 10 p.Article

Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessmentWISNIOWSKA, Barbara; MENDYK, Aleksander; FIJOREK, Kamil et al.JAT. Journal of applied toxicology. 2012, Vol 32, Num 9-10, pp 858-866, issn 0260-437X, 9 p.Article

Using Genome-Wide Association Studies to Identify Genes Important in Serious. Adverse Drug ReactionsDALY, Ann K.Annual review of pharmacology and toxicology (Print). 2012, Vol 52, pp 21-35, issn 0362-1642, 15 p.Article

Doxorubicin pathways: pharmacodynamics and adverse effectsTHORN, Caroline F; OSHIRO, Connie; MARSH, Sharon et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 7, pp 440-446, issn 1744-6872, 7 p.Article

Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a reviewMANDENIUS, Carl-Fredrik; STEEL, Daniella; SARTIPY, Peter et al.JAT. Journal of applied toxicology. 2011, Vol 31, Num 3, pp 191-205, issn 0260-437X, 15 p.Article